Skip to main content
Clinical Trials/NCT05016453
NCT05016453
Completed
Not Applicable

Long-term Efficacy of Percutaneous Tibial Nerve Stimulation for Faecal Incontinence and New Approach for Partial Responders

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana1 site in 1 country139 target enrollmentJanuary 8, 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Faecal Incontinence
Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Enrollment
139
Locations
1
Primary Endpoint
Change in faecal incontinence assessed by Wexner Score
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Percutaneous tibial nerve stimulation (PTNS) is an ambulatory therapy validated for patients with Faecal Incontinence (FI) refractory to conservative treatment with proved short and mid-term efficacy.

The investigators therefore aimed to evaluate the long-term efficacy of PTNS, considered 3 years of follow-up. The investigators also aimed to identify predictors of responses and suggest a new approach for partial responders.

Detailed Description

Prospective single-centre cohort of patients with FI treated with PTNS was analysed. PTNS sessions were performed in three phases: weekly for three months in the first phase, biweekly for three months in the second phase, and monthly for six months in the third and final phase. Clinical control at the end of each phase and an additional follow-up was performed at 36 months. Wexner score, faecal urgency, bowel habits and quality of life for FI were assessed. Patients were categorized in three groups: optimal responders when there was an improvement in Wexner score \> 50%; partial responders if the improvement in Wexner score was 25-50%; and non-responders, when the improvement of Wexner score was \< 25%. Optimal responders and partial responders progressed into successive phases, whereas non-responders abandoned PTNS and other treatment options were offered.

Registry
clinicaltrials.gov
Start Date
January 8, 2010
End Date
April 24, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Responsible Party
Principal Investigator
Principal Investigator

Luis Sánchez Guillen

Clinical Professor Luis Sánchez-Guillén

Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana

Eligibility Criteria

Inclusion Criteria

  • Diagnosis of faecal incontinence for more than 6 months, refractory to conservative treatment.

Exclusion Criteria

  • Anatomic injuries that require surgery.
  • External anal sphincter lesion of \> 180º.
  • Unavailability to attend regularly outpatient clinic.
  • Major psychologic or psychiatric comorbidities

Outcomes

Primary Outcomes

Change in faecal incontinence assessed by Wexner Score

Time Frame: Baseline compared to 3, 6, 12 and 36 months after start of PTNS

Rate of patients with improvement in faecal incontinence assessed by Wexner score (Maximum punctuation: 20 being severe incontinence. Minimum punctuation: 0, no incontinence).

Secondary Outcomes

  • Predictors of good long-term improvement in Wexner score(At 3, 6 and 12 months after start of PTNS)
  • Partial Responders(At 3, 6 and12 months after start of PTNS)

Study Sites (1)

Loading locations...

Similar Trials